Venous thromboembolism (VTE) is a recognized risk after total knee arthroplasty (TKA).1 While nearly all orthopedic surgeons agree that pharmacologic prophylaxis is the standard of care, major disagreements remain about the optimal, or even acceptable, medication regimens. Even evidence-based guidelines from different national societies,2,3 using the same published literature, often make different recommendations.4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Sterling RS, Haut ER. Should Aspirin Be Routinely Used for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty? Even the Authors of This Commentary Cannot Agree. JAMA Surg. 2019;154(1):72–73. doi:10.1001/jamasurg.2018.3859
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: